We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I see in the small print for the reviews that the supplier presumably Coopers may use your data to get in contact with the reviewer, this may give them an indication of whether the review is actually genuine or just part of a disruptive campaign.
Boots have just uploaded another 10 reviews in one swathe. Most of them 1 star and a lot of likes for the 1 star reviews!?!
C'mon Guys and Gals!! get your partner, mother, brother sister, cats aunts hairdresser, to leave positive reviews over the weekend, or the reviews may slip under 50% for recommending the product!
I’m pretty sure that there will be another RNS soon as he mentioned in the interview that there was more to come but he said “ I can’t comment on this at the moment “. The weeks leading up to June will be very interesting especially FDA announcement. That is a sure looking at reports. Good upside from here with the short term possibly of 100% lift in the SP.
There is not much point doing national campaign in UK at present as only sold in around 2200 Boots shops.
If they did one now everyone will think its only sold in Boots, and in a few months who knows, it could be in major supermarkets, H&B, Superdrug etc ... I imagine that would be the time to do a national campaign.
well that may or may not be true(certainly could be),but what i think is undeniable is that if they can market/promote as "fda approved" it is going to increase the effectiveness of any campaign dramatically.
I still think they are awaiting the FDA decision before deciding on how to move forward at scale.
It's in investment articles yes, it should be promoted to the main public.
It’s all over the internet and has been in many news reports so I’m a bit confused with your comment? This is an early stage available product remember.
Has anyone noticed this being sold at airports in Boots outlets?
Granted someone who first language is not English may not even notice it, but still.
God alone knows where and how Coopers are promoting Eroxon. There really appears to be nothing happening on this front. For anyone who is unaware of the product how you would find it or come across it I really do not know. I’ve put many different titles not including Eroxon into Google and I do not think it has come up once. Coopers don’t even have it on their latest news on their site. Bottom line as far as I can see there is simply nothing happening.
@Belgianbert. Global markets or takeover?
@Surf1, Buy the rumour, Sell the news!
FDA approval will significantly increase the SP in my opinion and many others.. Should start to move soon I imagine in anticipation
Last Sunday Mail 'City Whispers' column was headed ' Erectile dysfunction firm is hoping to boost its mojo'.
Whilst nothing new for LTHs in the article, it reckons Furtura could be on course for global domination and points out that the US is the next big goal and after that the focus will turn more to Asia. It concludes " Perhaps this will provide a longer-lasting rise in the shares, as a 26% spike in the wake of the UK launch has lost steam".
All good publicity in my opinion.
widowed twice gf is legit!
Don’t tell your wife your girlfriends are buying sticky gel for you….
My girl friends asked for Eroxon (starts off as if erotic) in a large branch. The assistant took her to the display and was totally au fait with the marketing and the product. very satisfactory
Nice 100,000 buy come through, somebody is confident… Always a good sign
Yet in the announcement on 29th March 2023 they state.
Based on the FDA's published target review period guidelines which includes time to review the newly provided information, the Board continue to anticipate grant of the De Novo request in Q2 2023.
So, actually anytime from now until the end of June.
Just need a couple of things to go in our favour and the future here should be one of years of growth. Just need the FDA approval and the licensee extension, as these will will add tremendous value to what is already a valuable proposition going forward.
Its surely not much to ask for on AIIM !
Results, announced in August, demonstrated that all primary and secondary endpoints had been met, with a “highly favourable” safety and tolerability profile and no serious adverse events.
The company said the FDA had now confirmed that the dossier was under formal review, and had indicated that it had successfully passed initial technical screening.
Based on the FDA's published target review period guidelines, granting of marketing authorisation remained on track to be achieved by the end of the first quarter of 2023, in line with its previously-announced timelines.
Could be any day from now.
Surfie, sir, nothing in this lifw is 100% certain apart from death, taxes and watford fc never wining the FA cup. It is all a gamble on any stock, and company as to the success they will achieve. This has the potential for massive gains.. hold on for the ride.
Just had a catch up and chuckle at the positive and negative reviews on Boots, about Eroxon
It no longer seems to be a coincidence, that almost every 1 star review always refers to "money wasted" in their post?!?!
RE Jet's comment about LOM taking some profit and a nice business to be in, I feel that is just reward for the steadfast way they've backed FUM, even in the dark old days of P3 failure. In my book they can do no wrong. But there again I'm a fairly naive investor, just hoping to make a bit of money towards my trip to Fantasy Island! I can't see 81lucky's predictions all coming true though, I expect I'll sell after the FDA rocket. This share hasn't been great for my blood pressure, even though I'm up at the moment! GLA!
I bought half my holding at a good price of about 15p years ago. I bought quarter at about 70p after EU approval [massive mistake] and the rest somewhere between 30/40p. This share has been all over the place in the last few years sometimes for a reason, sometimes not. I think it’s just worn me out where my head says take the profit while you still can. Heart says if certain things happen this reaches £2 plus easily and I can retire. It’s not been an easy journey as anyone who has been here years will know.